Aptivus® | Boehringer Ingelheim
Aptivus®
tipranavir
About Aptivus®
Indicated for combination antiretroviral treatment of HIV-1-infected patients, co-administered with 200 mg of ritonavir, who are treatment-experienced and infected with HIV-1 strains resistant to more than one protease inhibitor.
Product Key Facts
Indications
HIV/AIDS
Brand Names
Aptivus®
Active ingredients
tipranavir